Cadila Healthcare’s Baddi Plant successfully obtains the
Establishment Inspection Report (EIR) from the USFDA – Long term positive as it
could help pave new way for product approvals from this site.
·Aurobindo receives USFDA approval for
Norethindrone Acetate Tablets
Aurobindo Pharma receives USFDA approval for Norethindrone Acetate
Tablets – Positive Aurobindo Pharma announces that it has received final
approval from the US Food & Drug Administration ( USFDA) to manufacture and
market Norethindrone Acetate Tablets. Norethindrone Acetate Tablet is used in
the treatment of endometriosis, uterine bleeding caused by abnormal hormone
levels, and secondary amenorrhea. This is the 57th ANDA to be approved out of
Unit VII formulation facility in Hyderabad, India for manufacturing Oral
Non-Antibiotic products. Aurobindo now has a total of 230 ANDA approvals (199
Final approvals including 10 from Aurolife Pharma LLC and 31 Tentative
approvals) from USFDA.
·Tata Motors gains on strong JLR global retail
volumes
Shares of auto major gained over 2% to Rs361 on NSE in an
otherwise volatile markets as the Jaguar Land Rover December 2015 global retail
volumes were up by 19.7% YoY to 49,553 units; Strong growth in developed
economies. Jaguar volumes were up 20.4% YoY to 8,382 units. The growth
was largely attributable to the new XE which retailed 3,952 units. Land Rover
volumes for the month were up by 19.6% YoY at 41,171 units. The newly launched
Discovery Sport retailed 10,048 units which aided growth. The developed economies
performed well for JLR with UK retails growing 31.9%, North America volumes
higher by 29.7% and an impressive 50.2% growth in rest of Europe. However,
China sales for the month were weak and down 10.3% YoY at 10,403 units. Rest of
the world sales were up 15.9% to 9,675 units..
·L&T to get major share in Rs5,000-crore
Russian deal
As per media reports, Larsen and Toubro is set to get a major
share in a Rs5,000-crore deal to upgrade and refit Russian-origin Kilo class
submarines. Kilo class refit is a program to increase the life of the submarine
by 10 years involving complex engineering. – Positive for L&T
·Maruti to launch Vitara Brezza in February;
stock up
Maruti’s upcoming compact SUV to be named as Vitara Brezza; to be
launched in February Maruti Suzuki’s upcoming compact SUV has been named as
Vitara Brezza. The vehicle will be positioned as an urban SUV and will be
launched in February 2016 at the Auto Expo. Positive for the company. The stock
opened at Rs4190 on NSE and is currently trading at Rs4251, up by 1% in an
otherwise weak markets.
Get real time advice for Intraday Trading Tips , Share Market Tips , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates .
Get real time advice for Intraday Trading Tips , Share Market Tips , Intraday Equity Tips , Stock Trading tips , Free Intraday Tips , Best Accurate Stock Tips , NSE Stock market Tips and all Maket Updates .
0 comments:
Post a Comment